News

Armenia's Foldink builds all-Armenian multi-material bioprinter with TI-3D

What's the deal? Yerevan bioengineering startup FoldinkDealroom has a profile for this one. Try Dealroom → is co-developing a new compact bioprinter, the Foldink TI3D Ontogenesis, with Armenian firm TI-3D. The device will print with four or more biological materials at once while staying far smaller than rival systems, chief executive officer Vahan Grigoryan told Business Daily.

What does Foldink do? It makes 3D bioprinters and the bioinks that feed them. Scientists mix those materials with living cells and print structures that mimic tissue, used in regenerative medicine, drug discovery, cosmetics testing, and cell-based food.

Why now? Ontogenesis marks a step up from Foldink's entry-level X-TRUDR5, a single-extruder printer built with China's Wanhao for beginner labs. The new machine runs entirely on an Armenian base.

What's the endgame? Ontogenesis uses a modular design that can scale to five, six, or more extruders without growing in size. Six-extruder printers on the market are roughly the size of a desk, Grigoryan said, while Ontogenesis will be much smaller — helping labs print complex constructs in tighter spaces. The device includes an undisclosed component that Foldink says will enable printing with many materials, in large volumes, under higher sterility.

Where does it sell? All of Foldink's customers are abroad; it says no other bioprinting company operates in Armenia or the region. Core sales come from Western Europe and North America, with recent entries into Russia and Eastern Europe, and talks underway with buyers in China, Japan, and the Far East.

Foldink builds to order rather than in series, a model it plans to keep. The market is narrow, and each research lab needs a specific configuration, so pricing depends on the order and delivery location.

What could go wrong? Ontogenesis is still in development, with no launch date set. Its payoff will hinge on proven performance, customer uptake, and whether Foldink can grow its export sales.

The signal: Bioprinting is drawing attention, from the US ARPA-H's organ-printing program to CollPlant's new material kit. But those are research and materials moves; a compact, multi-material printer from a small Armenian startup is a bet that labs want more capability without the footprint.

Read more: businessdaily.am

Image credit: "3-D Bioprinting" by NIH-NCATS, public domain (Public Domain Mark 1.0)

More top stories